1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

Aurobindo Pharma Japan Kk | Products Portfolio

Aurobindo Pharma Japan Kk Suppliying Email

Back

Download Excel File

Show entries

Search:

Product Name	Forms	CAS No	Product Application	Supplier Name	Company Category	Certification	FY 2020 To 2021	FY 2021 To 2022	FY 2022 To 2023	Annual Supplying Capacity KG	Contact Person	Designation	Email Id	Contact Number	Contact Details	Country	Continent	Region

Product Name	Forms	CAS No	Product Application	Supplier Name	Company Category	Certification	FY 2020 To 2021	FY 2021 To 2022	FY 2022 To 2023	Annual Supplying Capacity KG	Contact Person	Designation	Email Id	Contact Number	Contact Details	Country	Continent	Region
Sertraline Hydrochloride	--	79559-97-0, 79645-15-1	Pharmaceuticals	Aurobindo Pharma Japan Kk	Manufacturer	US-FDA, EDQM/EMA/EU-GMP, WHO-GMP/WHO-CGMP, MHRA UK, ISO 9001:2000, BRAZIL-ANVISA	--	839.7	839.7	836.76	Nobuo Taku	Chief Executive Officer	--	81-3-32492261	9Th Floor Youth Building Cho Ku 103 0002 138 Nihonbashibakuro Cho Tokyo Japan	Japan	Asia	East Asia

Showing 1 to 2 of 2 entries

Previous1Next

Cookies & Privacy

This website uses ‘cookies’ to operate our site and personalize your digital experience. By continuing to browse this website, you agree to the terms outlined in our Privacy Policy, Cookies Policy

Aurobindo Pharma Japan Kk Suppliying Email

Advance Filter

Cookies & Privacy

Select cookies to accept